Devices Adapted to CMICS phaco

Article

Study shows reproducibility with devices dedicated to standardizing capsulorhexis

In the the last few months, forceps dedicated to CMICS incision have been developed. In a previous study, we have shown a high level of efficiency and safety, and no major difficulties, using this kind of device. However, we did not evaluate then the capsulorhexis quality created with these forceps.1

We performed a propspective study including 36 consecutive cases of capsulorhexis performed by 2 residents using 1.8 mm CMICS phacoemulsification. The population was randomly distributed into 3 groups and the capsulorhexis was done using 3 different devices (Figures 1–3):

The following parameters have been analysed: diameter, centration and regularity of the caspulorhexis, duration of the rhexis procedure as well as intraoperative complications (capsular tear, posterior capsule rupture). The subjective degree of difficulty in creating an optimal capsulorhexis was also evaluated using a questionnaire.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.